SciDev.Net (London)
21 November 2008
A pioneering attempt to commercialise an indigenous treatment for sickle cell anaemia is in serious trouble after the US-based company owning the rights to its development filed for bankruptcy.
[ See Article ]
Top | Site Français | Mobile | Who We Are | Advertising | Search My Account | Make us your home page | RSS | Contact | Privacy